Colored Gold Ions Enabled High-Transparent and Low-Haze Cellulose Films with Excellent Flame-Retardant and UV to Blue Light-Blocking Performance by Qiu Fu (10830823)

Subjects:

Colored Gold Ions Enabled High-Transparent and Low-Haze Cellulose Films with Excellent Flame-Retardant and UV to Blue Light-Blocking Performance by Qiu Fu (10830823)

Subjects:

Colored Gold Ions Enabled High-Transparent and Low-Haze Cellulose Films with Excellent Flame-Retardant and UV to Blue Light-Blocking Performance by Qiu Fu (10830823)

Subjects:

Colored Gold Ions Enabled High-Transparent and Low-Haze Cellulose Films with Excellent Flame-Retardant and UV to Blue Light-Blocking Performance by Qiu Fu (10830823)

Subjects:

Participant characteristics. by Ronald Kusolo (13200268)

Subjects:

Uganda 2023 NCD risk factor STEPS survey data. by Ronald Kusolo (13200268)

Subjects:

Uganda 2014 NCD risk factor STEPS survey data. by Ronald Kusolo (13200268)

Subjects:

S2 Appendix - by Shaaista Budhani (21030221)

“…There was a trend of increased recall rates in group 2 for short-term problems, long-term problems, intervention, and incidence rates, but it did not reach statistically significant level. There was an overall decrease in State Trait Anxiety Inventory (STAI) scores of participants after counseling (p = 0.002) but no statistically difference in change of STAI scores between the two groups (p = 0.981).…”

Outcomes and interventions by group comparison. by Shaaista Budhani (21030221)

“…There was a trend of increased recall rates in group 2 for short-term problems, long-term problems, intervention, and incidence rates, but it did not reach statistically significant level. There was an overall decrease in State Trait Anxiety Inventory (STAI) scores of participants after counseling (p = 0.002) but no statistically difference in change of STAI scores between the two groups (p = 0.981).…”

S1 Fig.pdf - by Shaaista Budhani (21030221)

“…There was a trend of increased recall rates in group 2 for short-term problems, long-term problems, intervention, and incidence rates, but it did not reach statistically significant level. There was an overall decrease in State Trait Anxiety Inventory (STAI) scores of participants after counseling (p = 0.002) but no statistically difference in change of STAI scores between the two groups (p = 0.981).…”

Baseline characteristics of participants. by Shaaista Budhani (21030221)

“…There was a trend of increased recall rates in group 2 for short-term problems, long-term problems, intervention, and incidence rates, but it did not reach statistically significant level. There was an overall decrease in State Trait Anxiety Inventory (STAI) scores of participants after counseling (p = 0.002) but no statistically difference in change of STAI scores between the two groups (p = 0.981).…”

Participant enrollment. by Shaaista Budhani (21030221)

“…There was a trend of increased recall rates in group 2 for short-term problems, long-term problems, intervention, and incidence rates, but it did not reach statistically significant level. There was an overall decrease in State Trait Anxiety Inventory (STAI) scores of participants after counseling (p = 0.002) but no statistically difference in change of STAI scores between the two groups (p = 0.981).…”

S1 Appendix - by Shaaista Budhani (21030221)

“…There was a trend of increased recall rates in group 2 for short-term problems, long-term problems, intervention, and incidence rates, but it did not reach statistically significant level. There was an overall decrease in State Trait Anxiety Inventory (STAI) scores of participants after counseling (p = 0.002) but no statistically difference in change of STAI scores between the two groups (p = 0.981).…”

S1 Protocol - by Shaaista Budhani (21030221)

“…There was a trend of increased recall rates in group 2 for short-term problems, long-term problems, intervention, and incidence rates, but it did not reach statistically significant level. There was an overall decrease in State Trait Anxiety Inventory (STAI) scores of participants after counseling (p = 0.002) but no statistically difference in change of STAI scores between the two groups (p = 0.981).…”

Expression of <i>EBI2, CH25H, CYP7B1</i> and <i>HSD3B7</i> enzymes in human brain vascular cells. by Fionä Caratis (12759506)

Subjects:

The CYP7B1 inhibitor, clotrimazole, and the EBI2 receptor antagonist, NIBR189, attenuate LPS-induced astrocyte migration <i>in vitro.</i> by Fionä Caratis (12759506)

Subjects:

The mRNA expression levels of <i>EBI2, CH25H</i>, <i>CYP7B1</i> and <i>HSD3B7</i> in mouse and human brains, isolated brain microvessels and human vascular cells under normal and i... by Fionä Caratis (12759506)

Subjects:

The oxysterol 7α, 25OHC synthesising and degrading enzymes are expressed in the mouse brain microvessels. by Fionä Caratis (12759506)

Subjects:

Tight junction and adhesion proteins in the brain are downregulated during systemic inflammation. by Fionä Caratis (12759506)

Subjects:

I.p. injection of LPS induces inflammation in the brain A. by Fionä Caratis (12759506)

Subjects: